• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome.

作者信息

Longobardo Alessia, Montanari Cecilia, Shulman Robert, Benhalim Suzanne, Singer Mervyn, Arulkumaran Nishkantha

机构信息

Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK.

Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK.

出版信息

Br J Anaesth. 2021 Jan;126(1):e44-e46. doi: 10.1016/j.bja.2020.10.011. Epub 2020 Oct 14.

DOI:10.1016/j.bja.2020.10.011
PMID:33138964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7556790/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4019/7556790/8db9c3453f41/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4019/7556790/8db9c3453f41/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4019/7556790/8db9c3453f41/gr1_lrg.jpg

相似文献

1
Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome.吸入一氧化氮对新型冠状病毒肺炎相关急性呼吸窘迫综合征患者的氧合改善作用甚微。
Br J Anaesth. 2021 Jan;126(1):e44-e46. doi: 10.1016/j.bja.2020.10.011. Epub 2020 Oct 14.
2
Association of Response to Inhaled Nitric Oxide and Duration of Mechanical Ventilation in Pediatric Acute Respiratory Distress Syndrome.儿童急性呼吸窘迫综合征中对吸入一氧化氮的反应与机械通气时间的关系。
Pediatr Crit Care Med. 2017 Nov;18(11):1019-1026. doi: 10.1097/PCC.0000000000001305.
3
Inhaled nitric oxide.吸入一氧化氮。
Crit Care Med. 1999 Apr;27(4):848-9. doi: 10.1097/00003246-199904000-00056.
4
Nitric oxide: how varied standards of ventilation affect study outcome.一氧化氮：不同的通气标准如何影响研究结果。
Crit Care Med. 1999 Apr;27(4):847-8. doi: 10.1097/00003246-199904000-00054.
5
Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.吸入一氧化氮治疗重症/危重症 COVID-19 患者的疗效和安全性：系统评价。
Indian J Pharmacol. 2021 May-Jun;53(3):236-243. doi: 10.4103/ijp.ijp_382_21.
6
Inhaled nitric oxide in patients with the acute respiratory distress syndrome secondary to the 2009 influenza A (H1N1) infection in Canada.加拿大2009年甲型H1N1流感感染继发急性呼吸窘迫综合征患者吸入一氧化氮的情况
Can J Anaesth. 2013 Feb;60(2):212-3. doi: 10.1007/s12630-012-9848-8. Epub 2012 Dec 7.
7
Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile?吸入一氧化氮治疗 COVID-19 诱导的 ARDS 的效果如何——是否值得？
Acta Anaesthesiol Scand. 2021 May;65(5):629-632. doi: 10.1111/aas.13757. Epub 2020 Dec 20.
8
Combination of inhaled nitric oxide therapy and inverse ratio ventilation in patients with sepsis-associated acute respiratory distress syndrome.吸入一氧化氮疗法与反比通气联合用于脓毒症相关急性呼吸窘迫综合征患者
Artif Organs. 2000 Nov;24(11):902-8.
9
Extracorporeal Membrane Oxygenation instead of Invasive Mechanical Ventilation in a Patient with Severe COVID-19-associated Acute Respiratory Distress Syndrome.体外膜肺氧合替代有创机械通气用于一名患有严重新型冠状病毒肺炎相关急性呼吸窘迫综合征的患者
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1571-1573. doi: 10.1164/rccm.202102-0259LE.
10
The effect of inhaled nitric oxide in acute respiratory distress syndrome in children and adults: a Cochrane Systematic Review with trial sequential analysis.吸入一氧化氮治疗儿童和成人急性呼吸窘迫综合征的效果：一项 Cochrane 系统评价与试验序贯分析。
Anaesthesia. 2017 Jan;72(1):106-117. doi: 10.1111/anae.13628. Epub 2016 Oct 20.

引用本文的文献

1
Inhaled nitric oxide for the treatment of COVID-19: an open-label, parallel, randomised controlled trial.吸入一氧化氮治疗新型冠状病毒肺炎：一项开放标签、平行分组、随机对照试验。
ERJ Open Res. 2025 Aug 26;11(4). doi: 10.1183/23120541.00006-2024. eCollection 2025 Jul.
2
Medium-Term Effect of Inhaled Nitric Oxide in Mechanically Ventilated COVID-19 Patients.吸入一氧化氮对机械通气的COVID-19患者的中期影响
J Clin Med. 2025 Jan 26;14(3):806. doi: 10.3390/jcm14030806.
3
Impact of low dose inhaled nitric oxide treatment in spontaneously breathing and intubated COVID-19 patients: a retrospective propensity-matched study.

本文引用的文献

1
Inhaled nitric oxide in patients admitted to intensive care unit with COVID-19 pneumonia.入住重症监护病房的新冠肺炎肺炎患者吸入一氧化氮的情况。
Crit Care. 2020 Aug 17;24(1):508. doi: 10.1186/s13054-020-03222-9.
2
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.严重 COVID-19 中的肺血管病：生理学、影像学和血液学观察。
Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699. doi: 10.1164/rccm.202004-1412OC.
3
Nitric oxide dosed in short bursts at high concentrations may protect against Covid 19.
低剂量吸入一氧化氮治疗有自主呼吸和插管的 COVID-19 患者的影响：一项回顾性倾向评分匹配研究。
Crit Care. 2024 Oct 25;28(1):344. doi: 10.1186/s13054-024-05093-w.
4
Inhaled Nitric Oxide ReDuce postoperatIve pulmoNAry complicaTions in patiEnts with recent COVID-19 infection (INORDINATE): protocol for a randomised controlled trial.吸入一氧化氮降低近期 COVID-19 感染患者术后肺部并发症（过度）：一项随机对照试验的方案。
BMJ Open. 2024 Mar 14;14(3):e077572. doi: 10.1136/bmjopen-2023-077572.
5
Unraveling the impact of nitric oxide, almitrine, and their combination in COVID-19 (at the edge of sepsis) patients: a systematic review.解析一氧化氮、阿米三嗪及其联合用药对新冠肺炎（处于脓毒症边缘）患者的影响：一项系统评价
Front Pharmacol. 2024 Jan 22;14:1172447. doi: 10.3389/fphar.2023.1172447. eCollection 2023.
6
High-flow nasal oxygen versus conventional oxygen therapy and noninvasive ventilation in COVID-19 respiratory failure: a systematic review and network meta-analysis of randomised controlled trials.高流量鼻氧疗与常规氧疗和无创通气治疗 COVID-19 呼吸衰竭的比较：一项随机对照试验的系统评价和网络荟萃分析。
Br J Anaesth. 2024 May;132(5):936-944. doi: 10.1016/j.bja.2023.12.022. Epub 2024 Feb 2.
7
The Potential Role of Nitric Oxide as a Therapeutic Agent against SARS-CoV-2 Infection.一氧化氮作为治疗 SARS-CoV-2 感染的潜在药物的作用。
Int J Mol Sci. 2023 Dec 5;24(24):17162. doi: 10.3390/ijms242417162.
8
Ventilatory Management of Patients with Acute Respiratory Distress Syndrome Due to SARS-CoV-2.新型冠状病毒肺炎所致急性呼吸窘迫综合征患者的通气管理
J Clin Med. 2023 Dec 5;12(24):7509. doi: 10.3390/jcm12247509.
9
Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia.拒绝 SARS-CoV-2：一氧化氮在治疗 COVID-19 肺炎中的潜力。
Med Gas Res. 2024 Apr-Jun;14(2):39-47. doi: 10.4103/2045-9912.385414.
10
Inhaled nitric oxide: can it serve as a savior for COVID-19 and related respiratory and cardiovascular diseases?吸入一氧化氮：它能成为治疗新冠肺炎及相关呼吸和心血管疾病的救星吗？
Front Microbiol. 2023 Oct 2;14:1277552. doi: 10.3389/fmicb.2023.1277552. eCollection 2023.
高浓度短时间内给予一氧化氮可能有助于预防新冠病毒 19（Covid-19）。
Nitric Oxide. 2020 Oct 1;103:1-3. doi: 10.1016/j.niox.2020.06.005. Epub 2020 Jun 23.
4
Treatment of COVID-19 by Inhaled NO to Reduce Shunt?吸入一氧化氮治疗新型冠状病毒肺炎以减少分流？
Am J Respir Crit Care Med. 2020 Aug 15;202(4):618. doi: 10.1164/rccm.202004-0940LE.
5
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
6
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.对新冠病毒疾病（COVID-19）患者的尸检显示，肺部出现弥漫性肺泡损伤，伴有严重的毛细血管充血，肺部及其他器官呈现出多样化的表现，提示存在血管功能障碍。
Histopathology. 2020 Aug;77(2):198-209. doi: 10.1111/his.14134. Epub 2020 Jul 5.
7
COVID-19 pneumonia: different respiratory treatments for different phenotypes?新冠肺炎：针对不同表型采用不同的呼吸治疗方法？
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
8
COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.新冠病毒肺炎不会导致“典型的”急性呼吸窘迫综合征。
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE.
9
Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.吸入一氧化氮用于儿童和成人急性呼吸窘迫综合征（ARDS）的治疗
Cochrane Database Syst Rev. 2016 Jun 27;2016(6):CD002787. doi: 10.1002/14651858.CD002787.pub3.
10
Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.全球 50 个国家重症监护病房急性呼吸窘迫综合征患者的流行病学、治疗模式和死亡率。
JAMA. 2016 Feb 23;315(8):788-800. doi: 10.1001/jama.2016.0291.